Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Giunta

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drugs of the Future|September 25, 2009
SOLUBLE CD40 LIGAND IN DEMENTIAB Giunta, K P Figueroa, T Town, et al.
Brain Research Bulletin|September 3, 2004
Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120B Giunta, J Ehrhart, K Townsend, et al.
Cell Death & Disease|August 15, 2014
Specific antibody binding to the APP672-699 region shifts APP processing from α- to β-cleavageS Li, J Deng, H Hou, et al.
Neurobiology of Disease|December 7, 2007
CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammationD Obregon, H Hou, Y Bai, et al.
Molecular Psychiatry|November 1, 2017
Blood-derived amyloid-β protein induces Alzheimer's disease pathologiesX-L Bu, Y Xiang, W-S Jin, et al.
Molecular Psychiatry|April 29, 2015
p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseX-Q Yao, S-S Jiao, K Saadipour, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drugs of the Future|September 25, 2009
SOLUBLE CD40 LIGAND IN DEMENTIAB Giunta, K P Figueroa, T Town, et al.
Brain Research Bulletin|September 3, 2004
Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120B Giunta, J Ehrhart, K Townsend, et al.
Cell Death & Disease|August 15, 2014
Specific antibody binding to the APP672-699 region shifts APP processing from α- to β-cleavageS Li, J Deng, H Hou, et al.
Neurobiology of Disease|December 7, 2007
CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammationD Obregon, H Hou, Y Bai, et al.
Molecular Psychiatry|November 1, 2017
Blood-derived amyloid-β protein induces Alzheimer's disease pathologiesX-L Bu, Y Xiang, W-S Jin, et al.
Molecular Psychiatry|April 29, 2015
p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseX-Q Yao, S-S Jiao, K Saadipour, et al.
Pageof 1